JP2006528617A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528617A5
JP2006528617A5 JP2006520897A JP2006520897A JP2006528617A5 JP 2006528617 A5 JP2006528617 A5 JP 2006528617A5 JP 2006520897 A JP2006520897 A JP 2006520897A JP 2006520897 A JP2006520897 A JP 2006520897A JP 2006528617 A5 JP2006528617 A5 JP 2006528617A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
group
optionally
aryl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006520897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528617A (ja
Filing date
Publication date
Priority claimed from GB0317346A external-priority patent/GB0317346D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/003184 external-priority patent/WO2005012263A1/en
Publication of JP2006528617A publication Critical patent/JP2006528617A/ja
Publication of JP2006528617A5 publication Critical patent/JP2006528617A5/ja
Withdrawn legal-status Critical Current

Links

JP2006520897A 2003-07-24 2004-07-23 5−ht2b受容体アンタゴニスト Withdrawn JP2006528617A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0317346A GB0317346D0 (en) 2003-07-24 2003-07-24 5-ht2b receptor antagonists
US49028603P 2003-07-28 2003-07-28
PCT/GB2004/003184 WO2005012263A1 (en) 2003-07-24 2004-07-23 5-ht2b receptor antagonists

Publications (2)

Publication Number Publication Date
JP2006528617A JP2006528617A (ja) 2006-12-21
JP2006528617A5 true JP2006528617A5 (enExample) 2007-09-06

Family

ID=34117640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006520897A Withdrawn JP2006528617A (ja) 2003-07-24 2004-07-23 5−ht2b受容体アンタゴニスト

Country Status (5)

Country Link
US (1) US20090018150A1 (enExample)
EP (1) EP1648876A1 (enExample)
JP (1) JP2006528617A (enExample)
CA (1) CA2532505A1 (enExample)
WO (1) WO2005012263A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005097113A2 (en) * 2004-04-08 2005-10-20 Pharmagene Laboratories Limited 5-ht2b receptor antagonists
US8569352B2 (en) 2005-06-27 2013-10-29 Exelixis Patent Company Llc Imidazole based LXR modulators
SG162803A1 (en) * 2005-06-27 2010-07-29 Exelixis Inc Imidazole based lxr modulators
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
CN101679297B (zh) 2006-12-08 2012-01-11 埃克塞利希斯股份有限公司 Lxr和fxr调节剂
EP2053920B1 (en) 2007-01-26 2014-04-30 North Carolina State University Inhibition of bacterial biofilms with imidazole derivatives
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
EP2224809A4 (en) 2007-11-27 2014-06-11 Univ North Carolina State INHIBITION OF BIOFILMS IN PLANTS WITH IMIDAZOLE DERIVATIVES
MY152486A (en) 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
US9005643B2 (en) 2008-04-04 2015-04-14 North Carolina State University Inhibition of bacterial biofilms with imidazole-phenyl derivatives
WO2009131654A2 (en) 2008-04-21 2009-10-29 North Carolina State University Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
US8779158B2 (en) 2008-05-09 2014-07-15 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
WO2010017902A1 (de) * 2008-08-14 2010-02-18 Bayer Cropscience Aktiengesellschaft Insektizide 4-phenyl-1h-pyrazole
US20110294668A1 (en) 2008-12-08 2011-12-01 North Carolina State University Inhibition and dispersion of biofilms in plants with imidazole-triazole derivatives
WO2010144686A1 (en) 2009-06-10 2010-12-16 North Carolina State University Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives
WO2011015524A2 (en) * 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2513064B1 (en) 2009-12-17 2018-07-04 Katholieke Universiteit Leuven K.U. Leuven R&D Compounds, compositions and methods for controlling biofilms
WO2012135016A2 (en) 2011-03-25 2012-10-04 North Carolina State University Inhibition of bacterial biofilms and microbial growth with imidazole derivatives
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
US20160002180A1 (en) * 2013-03-05 2016-01-07 Hoffmann-La Roche Inc. Antiviral compounds
JP6163214B2 (ja) 2013-03-06 2017-07-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 抗ウイルス化合物
EP3119394B1 (en) 2014-03-19 2021-05-12 Curza Global LLC Compositions and methods comprising 2-(acylamino)imidazoles
JP6552061B2 (ja) 2014-06-10 2019-07-31 サンフォード−バーンハム メディカル リサーチ インスティテュート 代謝型グルタミン酸受容体の負のアロステリックモジュレーター(nams)とその使用
WO2018184019A1 (en) 2017-03-31 2018-10-04 Curza Global, Llc Compositions and methods comprising substituted 2-aminoimidazoles
TWI782504B (zh) * 2020-05-08 2022-11-01 美商美國禮來大藥廠 (三氟甲基)嘧啶-2-胺化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE492033A (enExample) * 1948-11-05
GB696692A (en) * 1950-12-06 1953-09-09 Ici Ltd New quinazoline derivatives
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
US5733932A (en) * 1995-01-06 1998-03-31 The Picower Institute For Medical Research Compounds and methods of use to derivatize neighboring lysine residues in proteins under physiological conditions
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
CA2445003A1 (en) * 2001-05-16 2002-11-21 Boehringer Ingelheim Pharmaceuticals, Inc. Diarylurea derivatives useful as anti-inflammatory agents
GB0203412D0 (en) * 2002-02-13 2002-04-03 Pharmagene Lab Ltd 5-HT 2B receptor antagonists
US6995181B2 (en) * 2002-07-18 2006-02-07 Bristol-Myers Squibb Co. Modulators of the glucocorticoid receptor and method
AU2003251969A1 (en) * 2002-07-18 2004-02-09 Bristol-Myers Squibb Company Compositions and methods involving nuclear hormone receptor site ii
DE60328035D1 (de) * 2002-11-29 2009-07-30 Banyu Pharma Co Ltd Neue azolderivate

Similar Documents

Publication Publication Date Title
JP2006528617A5 (enExample)
JP2009531376A5 (enExample)
JP2005537854A5 (enExample)
JP2005506338A5 (enExample)
JP2012092103A5 (enExample)
JP2007502287A5 (enExample)
JP2007530577A5 (enExample)
JP2011504903A5 (enExample)
JP2009526034A5 (enExample)
JP2011026326A5 (enExample)
JP2003531118A5 (enExample)
JP2009533343A5 (enExample)
JP2008526999A5 (enExample)
JP2013514980A5 (enExample)
JP2014514349A5 (enExample)
JP2008535903A5 (enExample)
JP2011500545A5 (enExample)
JP2011521911A5 (enExample)
JP2009511508A5 (enExample)
JP2006526590A5 (enExample)
JP2011526924A5 (enExample)
JP2013528180A5 (enExample)
JP2012513416A5 (enExample)
JP2019515908A5 (enExample)
JP2008540554A5 (enExample)